Auto Amazon Links: No products found. Blocked by captcha.
An official review has been launched into warnings on certain medications after a BBC investigation exposed inaccuracies in drug leaflets related to impulsive behaviours. These side effects, linked to a group of drugs prescribed for Parkinson’s disease, Restless Legs Syndrome (RLS), and other disorders, have been connected to serious personal consequences including addiction, financial struggles, damaged relationships, criminal acts, and even suicide. Over the course of a year, the BBC received outreach from more than 350 individuals affected by these issues.
Research indicates that impulse control disorders impact roughly one in six Parkinson’s patients treated with these drugs, which contradicts the wording found in some medication leaflets that label such behavioural side effects as “uncommon,” meaning they would affect less than one percent of users. Following the BBC’s disclosure, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) confirmed that an error had been identified for one drug in particular, Pramipexole, and announced plans to update the classification to “common.” Additionally, the MHRA has initiated a review of the safety warnings for all eight dopamine agonist drugs in this category.
Jane Ryde shared her personal experience with her late husband’s struggle after he was prescribed Pramipexole. He developed compulsive sexual behaviours, including pornography addiction and demanding sex multiple times daily, with no prior warning from his healthcare providers. Though the leaflet mentioned these side effects as “uncommon,” she now believes that description was misleading and contributed to a distressing decade-long ordeal. Jane emphasized the need for transparent, accurate information to prevent others from facing similar difficulties, stating, “You have to go into these things with your eyes open.”
Experts have pointed out that these side effects are often under-reported due to the shame associated with impulsive behaviours, and there is significant variation in how different drug manufacturers present risk information in leaflets. For example, the drug Ropinirole has no specific frequency noted for side effects, as its data is based solely on case reports. Clinical studies, including one from 2010 partially funded and designed by the manufacturer, indicate the real incidence of these impulse control disorders is closer to 14-17%, which
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found. Blocked by captcha.